Extremely significant negative changes in AngioDynamics Inc (NASDAQ: ANGO) investment behavior have recently occurred: the stock’s recent price decline challenged its longer term uptrend, its shorter term price trend turned down, and negative upside/downside volume developed.
Recent marginal negative changes in fundamentals have affected AngioDynamics Inc (NASDAQ: ANGO): significant quarterly sales deceleration occurred.
In light of these highly negative signals we are reviewing our current Overall Rating of F. We would continue to view the shares with caution pending completion of this review in the next several days.
Current PriceTarget Research Rating
ANGO’s future returns on capital are forecasted to be in line with the cost of capital. Accordingly, the company is expected to continue to be Value Creation neutral.
AngioDynamics has a current Value Trend Rating of F (Lowest Rating). This rating combines inconsistent signals from two proprietary PTR measures of a stock’s attractiveness. AngioDynamics has a neutral Appreciation Score of 48 but a very low Power Rating of 4, producing the Lowest Value Trend Rating.
Recent Price Action
AngioDynamics Inc (NASDAQ: ANGO) stock declined modestly by -1.1% on 6/14/24. The stock closed at $6.15. However, below average trading volume at 79% of normal accompanied the decline. Relative to the market the stock has been weak over the last nine months and has declined -5.7% during the last week.
Be the first to comment